Month: September 2018

Cerveau Technologies, Inc. Signs Research Agreement with Kobe City Hospital Organisation, Japan

At Cerveau Technologies we’re working towards the vision of globally developing diagnostics and technology in partnership with Enigma Biomedical Group and Sinotau Pharmaceutical Group. In turn, these developments can have a profoundly positive impact on patients suffering from neurodegenerative disorders, like Alzheimer’s disease. On June 22, Cerveau Technologies has signed an exciting agreement, one with ...

Enigma Biomedical Group and Invicro Sign a Collaboration Agreement

  At Enigma Biomedical group, we’re focused on molecular imaging and medicine. We’re on a mission to progress developmental studies in brain health and accelerate them by offering an array of services, so that they’re able to impact the world on a vast, global scale. From vaccine development to the revolution of genomics, we’re here ...